GaPP2, a multicentre randomised controlled trial of the efficacy of gabapentin for the management of chronic pelvic pain in women: study protocol

INTRODUCTION: Chronic pelvic pain (CPP) affects more than 1 million UK women with associated healthcare costs of £158 million annually. Current evidence supporting interventions when no underlying pathology is identified is very limited and treatment is frequently inadequate. Gabapentin (a GABA anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Vincent, Katy, Baranowski, Andrew, Bhattacharya, Siladitya, Birch, Judy, Cheong, Ying, Cregg, Roman, Daniels, Jane, Hewitt, Catherine A, Macfarlane, Gary J, Middleton, Lee, Szubert, Wojciech, Tracey, Irene, Williams, Amanda C de C, Horne, Andrew W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Obstetrics and Gynaecology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879736/
https://www.ncbi.nlm.nih.gov/pubmed/29391360
http://dx.doi.org/10.1136/bmjopen-2016-014924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879736/
https://www.ncbi.nlm.nih.gov/pubmed/29391360
http://dx.doi.org/10.1136/bmjopen-2016-014924

Ejemplares similares